Average Co-Inventor Count = 4.56
ph-index = 10
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Astex Therapeutics Limited (15 from 123 patents)
2. Warner-lambert Company (11 from 2,538 patents)
3. Cancer Research Technology Limited (5 from 262 patents)
4. The Institute of Cancer Research: Royal Cancer Hospital (1 from 51 patents)
5. Cancer Research Technology Limtied (1 from 1 patent)
6. The Institute of Cancer Research : the Royal Cancer Hospital (0 patent)
26 patents:
1. 12071429 - Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity
2. 11261171 - Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity
3. 10981898 - Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activity
4. 10544132 - Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activity
5. 10526311 - Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity
6. 9850228 - Pyrazolyl quinoxaline kinase inhibitors
7. 9464071 - Pyrazolyl quinoxaline kinase inhibitors
8. 9458158 - Bicyclic heterocycle compounds and their uses in therapy
9. 9155743 - Bicyclic heterocycle compounds and their uses in therapy
10. 8895601 - Pyrazolyl quinoxaline kinase inhibitors
11. 8778936 - Pyrazole compounds that modulate the activity of CDK, GSK and aurora kinases
12. 8497294 - Compositions comprising (S)-2-amino-1-(4-chlorophenyl)-1-[4-(1H-pyrazol-4-yl)-phenyl]-ethanol as modulator of protein kinases
13. 8293767 - 4-(2,6-dichloro-benzoylamino)-1H-pyrazole-3-carboxylic acid piperidin-4-ylamide acid addition salts as kinase inhibitors
14. 8110573 - Pyrazole compounds that modulate the activity of CDK, GSK and aurora kinases
15. 8013163 - 4-(2,6-dichloro-benzoylamino)-1H-pyrazole-3-carboxylic acid piperidin-4-ylamide acid addition salts as kinase inhibitors